Trends in lactose-derived bioactives: synthesis and purification
Carlos Vera , Cecilia Guerrero , Andrés Illanes
Systems Microbiology and Biomanufacturing ›› 2022, Vol. 2 ›› Issue (3) : 393 -412.
Trends in lactose-derived bioactives: synthesis and purification
Lactose obtained from cheese whey is a low value commodity despite its great potential as raw material for the production of bioactive compounds. Among them, prebiotics stand out as valuable ingredients to be added to food matrices to build up functional foods, which currently represent the most active sector within the food industry. Functional foods market has been growing steadily in the recent decades along with the increasing awareness of the World population about healthy nutrition, and this is having a strong impact on lactose-derived bioactives. Most of them are produced by enzyme biocatalysis because of molecular precision and environmental sustainability considerations. The current status and outlook of the production of lactose-derived bioactive compounds is presented with special emphasis on downstream operations which are critical because of the rather modest lactose conversion and product yields that are attainable. Even though some of these products have already an established market, there are still several challenges referring to the need of developing better catalysts and more cost-effective downstream operations for delivering high quality products at affordable prices. This technological push is expected to broaden the spectrum of lactose-derived bioactive compounds to be produced at industrial scale in the near future.
Prebiotic / Lactose / β-Galactosidase / Oligosaccharide purification / Engineering / Food Sciences
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
StrategyR. Prebiotics, global market trajectory & analytics. 2021. https://www.strategyr.com/market-report-prebiotics-forecasts-global-industry-analysts-inc.asp. Accessed 6 Aug 2021. |
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
Research and Market. Inulin market-forecasts from 2020 to 2025. 2021. https://www.researchandmarkets.com/reports/5238718/inulin-market-forecasts-from-2020-to-2025. Accessed 6 Aug 2021. |
| [26] |
Research and Market. Galacto-oligosaccharide (GOS). Global market trajectory & analytics. 2021. https://www.researchandmarkets.com/reports/5302733/galacto-oligosaccharide-gos-global-market. Accessed 6 Aug 2021. |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
Beadle JR, Saunders JP, Thomas J, Wajda J (1992) Process for manufacturing tagatose. United States Patent. US5078796A. |
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
Food Safety Authority of Ireland. Substantial equivalence opinion: D-tagatose, Dublin. 2016. https://www.fsai.ie/uploadedFiles/Science_and_Health/Novel_Foods/Notifications/Substantial%20equivalence%20opinion(1).pdf. Accessed 12 Sep 2021. |
| [83] |
Lee Y, Park I, Shin S, Yang S, Cho H, Kim S, Choi E. A fructose-C4-epimerase and preparation methods for producing tagatose using the same, US 2020/0263217 A1. 2020. |
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
GRAS Associates. Gras notice 729. Galactooligosaccharides (GOS), food usage conditions for general recognition of safety. 2017. https://www.fda.gov/media/111860/download . Accessed1 Sept 2021. |
| [102] |
Spherix Consulting Inc. Gras notice 334. Generally recognized as safe (GRAS) determination for the use of galacto-oligosaccharides (GOS) in foods and infant formulas. 2010. http://wayback.archive-it.org/7993/20171031050145/. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/UCM269519.pdf. Accessed 1 Sep 2021. |
| [103] |
|
| [104] |
Nestle Nutrition U.S. GRAS notice 620. GRAS Exemption Claim for Galacto-ligosaccharides. 2016. https://wayback.archive-it.org/7993/20190208035755/. Accessed 1 Sept 2021. |
| [105] |
Clasado Inc. GRAS Notice 484. GRAS Exemption Claim for Galacto-oligosaccharides. 2013. http://wayback.archive-it.org/7993/20171031055001/. Accessed 1 Sept 2021. |
| [106] |
Friesland Foods Domo. Gras notice 236. GRAS exemption claim for galacto-oligosaccharides (GOS). 2007. https://wayback.archive-it.org/7993/20190208035755/. Accessed 1 Sept 2021. |
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
GTC Nutrition. GRAS notice 285. Galactooligosaccharide GRAS notice. 2009. http://wayback.archive-it.org/7993/20171031055001/. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm269255.pdf. Accessed 1 Sept 2021. |
| [136] |
Nutrasource Inc. GRAS notice 352. GRAS exemption claim for D-tagatose as an ingredient in foods. 2010. http://wayback.archive-it.org/7993/20171031055001/. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm269560.pdf. Accessed 1 Sept 2021. |
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
|
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
|
| [165] |
|
| [166] |
|
| [167] |
|
| [168] |
Okabe T, Aga H, Kunota H, Miyake M. Lactosucrose high content saccharide, its preparation and uses. U.S. 20080027027A1. 2008. |
| [169] |
Soni & Associates Inc. GRAS notice 569. GRAS Notification for galacto-oligosaccharide (infant formula use). 2015. http://wayback.archive-it.org/7993/20171031055001/. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm475293.pdf. Accessed 1 Sept 2021. |
| [170] |
|
| [171] |
|
| [172] |
|
| [173] |
|
| [174] |
|
Jiangnan University
/
| 〈 |
|
〉 |